News
Pharmaceutical Technology on MSN5d
Teva brings first generic GLP-1 to US market with Saxenda copycat approval
Although Saxenda is the first generic GLP-1 to hit the US market, its sales will likely be overshadowed by next-gen drugs ...
Generic Saxenda® is the first-ever generic GLP-1 indicated for weight loss, addressing increased demand for this category of therapies in the ...
Teva is releasing a generic version of Novo Nordisk’s Saxenda, a liraglutide injection. Liraglutide injection is indicated for adults with obesity or overweight who also have weight related medical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback